Abstract
Patients in the intensive care unit frequently experience delirium, anxiety, and agitation, with a variety of treatments used. This article discusses the role of an [alpha]-adrenoceptor agonist, dexmedetomidine, and its clinical relevance and advantages for the agitated patient.